找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology; Scientific and Clini Mohammad Resa Nowrousian Book 2008Latest edition Spring

[复制链接]
查看: 14499|回复: 63
发表于 2025-3-21 18:09:38 | 显示全部楼层 |阅读模式
书目名称Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
副标题Scientific and Clini
编辑Mohammad Resa Nowrousian
视频video
概述Comprehensive presentation of anemia in cancer and its treatment.Assessment of current and potential applications of erythropoietin.Presented by world experts in the field.Includes supplementary mater
图书封面Titlebook: Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology; Scientific and Clini Mohammad Resa Nowrousian Book 2008Latest edition Spring
描述Anemia is a frequent complication of cancer and its treatment. It produces many symptoms and significantly impairs metabolic and physiologic functions as well as patients‘ activity, well-being and quality of life. Life expectancy is also affected. This book, now being published in its second edition, comprehensively presents the current knowledge on anemia in cancer and its treatment with rhEPO. Future developments are also discussed. Based on updated and new chapters, including a broader spectrum of topics, outstanding international experts describe the scientific and clinical aspects of anemia in various fields of oncology and give diagnostic and therapeutic recommendations on when and how to use rhEPO. The book, considered as a standard work, will again serve as an essential source of information for radiotherapists, medical oncologists, hematologists, internists, pediatricians, surgeons, specialists in transfusion and laboratory medicine, and pharmacologists.
出版日期Book 2008Latest edition
关键词Fatigue; Tumor; anemia; chemotherapy; classification; hemoglobin; pathophysiology; physiology; radiation onc
版次2
doihttps://doi.org/10.1007/978-3-211-69459-6
isbn_softcover978-3-7091-1904-4
isbn_ebook978-3-211-69459-6
copyrightSpringer-Verlag Vienna 2008
The information of publication is updating

书目名称Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology影响因子(影响力)




书目名称Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology影响因子(影响力)学科排名




书目名称Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology网络公开度




书目名称Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology网络公开度学科排名




书目名称Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology被引频次




书目名称Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology被引频次学科排名




书目名称Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology年度引用




书目名称Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology年度引用学科排名




书目名称Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology读者反馈




书目名称Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:12:59 | 显示全部楼层
The role of erythropoietin receptor expression on tumor cells,a, such as the cancer associated anemia. Anemia is common in patients with malignant disease (.; .). It is either due to the myelosuppressive effects of chemotherapy and/or radiotherapy or sometimes infiltration of the bone marrow. In many cases, cancer patients suffer from the anemia of chronic dis
发表于 2025-3-22 02:38:50 | 显示全部楼层
发表于 2025-3-22 05:26:15 | 显示全部楼层
Definition, classification and characterization of anemia in cancer,aditionally used in the physical diagnosis of anemia are pallor of the conjunctivae, nail beds, face, palms, and palmar creases. Among these, only pallor of the conjunctivae, nail beds, and palms can be used in patients of any race. There is evidence suggesting that conjunctival pallor may be more s
发表于 2025-3-22 08:52:36 | 显示全部楼层
发表于 2025-3-22 13:48:07 | 显示全部楼层
发表于 2025-3-22 17:32:30 | 显示全部楼层
Significance of anemia in cancer chemotherapy,and incidence of anemia depend on one side on the type and stage of malignancy and on the other side on the type, schedule and intensity of treatment. Hematological malignancies, particularly myeloid disorders, are generally more often associated with anemia than solid tumors but, depending on the t
发表于 2025-3-22 22:46:16 | 显示全部楼层
发表于 2025-3-23 01:36:39 | 显示全部楼层
Tumor hypoxia and therapeutic resistance,e to the lack of methods suitable for the routine measurement of intratumoral oxygen tensions in patients. In the late 1980s, a novel and clinically applicable standardized procedure was established enabling the determination of tumor oxygenation in accessible primary tumors, local recurrences, and
发表于 2025-3-23 05:58:16 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-12 19:33
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表